Answers are grounded in this paper and cite their sources.
Lessel‑Kreienkamp syndrome (LESKRES) is a rare neurodevelopmental disorder caused by pathogenic variants in the AGO2 gene. The present study to the best of our knowledge, reports first case of LESKRES coexisting with mosaic Turner syndrome in a 30‑year‑old Korean woman who presented with lifelong developmental delay, intellectual disability, hypotonia, impaired speech development and characteristic craniofacial features. Whole‑exome sequencing identified a heterozygous de novo in‑frame deletion in AGO2 (NM_012154.4:c.544_546del; p.Phe182del), previously reported as pathogenic for LESKRES. The variant affects a residue at the base of the L1 linker, a hinge region implicated in RNA duplex unwinding. In addition, peripheral blood karyotyping revealed mosaic Turner syndrome [45,X(7)/47,XXX(2)/46,XX(51)]. However, the patient lacked typical Turner syndrome manifestations, including short stature and characteristic somatic features, suggesting that the neurodevelopmental phenotype was primarily attributable to the AGO2 variant. Although some minor craniofacial findings may have been influenced by Turner syndrome mosaicism, its overall clinical contribution appeared limited. In clinical genetic laboratories, even when an abnormal finding is identified through a specific genetic test, additional genetic investigations should be considered if the genotype‑phenotype correlation is not consistent with the patient's clinical presentation.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: